Intubation Decision‑Making in Neuromuscular Disease Based on Clinical Deterioration and NIV Failure

1. Guiding Principles for Intubation

• Intubation should not be based solely on a single NIF/MIP threshold; clinicians must consider overall clinical deterioration and evidence of non‑invasive ventilation (NIV) failure, and should not delay intubation when NIV is failing in patients with neuromuscular disease (NMD). 1, 2, 3
• The contemporary care model prioritises NIV as the first‑line respiratory support for NMD patients rather than proceeding directly to invasive ventilation based only on NIF values. 1, 2, 3
• Patients with NMD generally tolerate NIV well, whereas extubation from invasive mechanical ventilation can be extremely difficult in this population. 1, 2, 3

2. Criteria for Initiating NIV

• NIV should be started when Maximum Inspiratory Pressure (MIP/NIF) falls below –60 cm H₂O; this threshold signals significant inspiratory muscle weakness that compromises ventilation. 1
• Additional objective triggers for NIV initiation include:
  
  • Maximum Expiratory Pressure (MEP) < 40 cm H₂O, indicating severe expiratory muscle weakness and impaired cough. (cited in the same source as the MIP threshold)
  • Vital capacity (VC) < 1 L with respiratory rate > 20 breaths/min, even if the patient remains normocapnic. 1, 2, 3
• Early initiation of NIV before the development of respiratory acidosis is recommended for any breathless or acutely unwell NMD patient. 1, 2, 4

3. Indicators of NIV Failure Requiring Prompt Intubation

• Inability to clear secretions despite optimal secretion‑management strategies and cough‑assist devices. 1, 2, 3, 4
• Severe bulbar dysfunction that makes NIV delivery difficult or impossible. 1, 2, 3, 4
• Inadequate oxygenation or rapid desaturation during breaks from NIV. 3
• When any of the above signs are present, intubation should be performed without delay, provided invasive ventilation aligns with the patient’s goals of care. 1, 2, 3

4. Practical Management Recommendations

5. Common Pitfalls to Avoid

• Do not wait for respiratory acidosis before starting NIV in NMD patients; intervene early based on MIP/NIF and clinical signs. 1, 2, 4
• Do not rely on a single NIF value as the sole determinant for intubation; evaluate the full clinical picture, including secretion clearance, bulbar function, and NIV response. 1, 2, 3
• Do not delay intubation when clear signs of NIV failure are present, as postponement increases morbidity and mortality. 1, 2, 3

Respiratory Management in Motor Neuron Disease

Introduction to Respiratory Care

• The American Thoracic Society recommends initiating noninvasive ventilation (NIV) immediately when pulmonary function criteria are met or symptoms develop in patients with Motor Neuron Disease (MND), using individualized pressure settings with ongoing optimization of secretion management, and not delaying intubation if NIV fails 5, 6

Monitoring and Early Detection

• Perform pulmonary function testing every 6 months minimum to detect respiratory decline before crisis develops, measuring Forced Vital Capacity (FVC) or slow vital capacity (SVC), Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP), and Peak Cough Flow (PCF) 5, 7, 8
• Recognize early symptoms of respiratory insufficiency that warrant immediate evaluation, including morning headaches, concentration or memory difficulties, orthopnea or shortness of breath, and unrefreshing sleep with snoring, gasping, or witnessed apneas 9, 10, 11

Criteria for NIV Initiation

• Initiate NIV when any of the following criteria are met: FVC <80% predicted with symptoms, FVC <50% predicted without symptoms, MIP <60 cm H₂O, MEP <40 cm H₂O, PCF <270 L/min, or SpO₂ ≤90% for ≥2% of sleep time 9, 10

NIV Settings and Optimization

• Use controlled ventilation modes as triggering may be ineffective in MND, with initial pressure support typically 8-12 cm H₂O pressure difference, and optimize NIV by adjusting mode of ventilation, inspiratory time, and inspiratory and expiratory pressures 5, 6, 7

Secretion Management

• Implement aggressive secretion clearance strategies, including oral anticholinergic medication, botulinum toxin injections, lung volume recruitment, and mechanical insufflation-exsufflation (MI-E) 11, 12

Daytime Ventilatory Support

• Consider mouthpiece ventilation (MPV) for daytime ventilatory support as an adjunct for patients with preserved bulbar function using nocturnal NIV 5, 6, 7

Transition to Invasive Mechanical Ventilation

• Consider invasive home mechanical ventilation via tracheostomy when NIV fails or patient is intolerant of NIV, worsening bulbar function develops, frequent aspiration occurs, or insufficient cough persists despite adequate secretion management 5, 7, 11

Oxygen Therapy

• Use controlled oxygen therapy cautiously to achieve target saturations of 88-92%, as supplemental oxygen corrects hypoxemia without treating underlying hypoventilation or atelectasis and may impair central respiratory drive 13, 12, 11

Critical Pitfalls to Avoid

• Do not wait for respiratory acidosis to develop before initiating NIV in MND patients, and do not delay intubation if NIV is failing, unless escalation to invasive ventilation is not desired by the patient or deemed inappropriate 6, 13